Image via Wikipedia
Halfway through February, the National Swiss Fund has established a national plan for stem cell research and regenerative medicine, providing 10 million francs (6,766,000 euros) in financing over 5 years. In November, the Foundation will make a decision on projects that have already been submitted. In January 2010, those which have been approved will get underway. The objective is to favor basic biological stem cell and regenerative medicine research, and to spread awareness internationally.
At the end of 2004 in a referendum, Swiss citizens approved a law that allows the use of excess embryonic
Image via Wikipedia
Scientists may be growing impatient, but President Obama has been rightly taking his time in addressing a campaign promise to lift the ban on federal funding for research using new lines of stem cells to be taken from human embryos. Even for strong backers of embryonic stem cell research, the decision is no longer as self-evident as it was, because there is markedly diminished need for expanding these cell lines for either patient therapy or basic research. In fact, during the first six weeks of Obama’s term, several events reinforced the notion that embryonic stem cells, once
The latest developments in molecular biology in the prenatal diagnostic field, particularly regarding preserving stem cells extracted from amniotic liquid, were the focus of the latest S.I.Di.P conference (Italian Society of Prenatal Diagnosis and Maternal Fetal Medicine).
After a greeting from S.I.Di.P President Claudio Giorlandino and President of the Italian Gynecology and Obstetrics Society Giorgio Vittori, Professor Giuseppe Simone, the head of the Biocell Center in Busto Arsizio (VA), the first Italian center able to treat and store stem cells extracted from the amniotic liquid in liquid nitrogen, opened the conference.
“In the next five to ten years,” explained Professor Simoni,
In the beginning, one cell becomes two, and two become four. Being fruitful, they multiply into a ball of many cells, a shimmering sphere of human potential. Scientists have long dreamed of plucking those naive cells from a young human embryo and coaxing them to perform, in sterile isolation, the everyday miracle they perform in wombs: transforming into all the 200 or so kinds of cells that constitute a human body. Liver cells. Brain cells. Skin, bone, and nerve.
James A. Thomson
The dream is to launch a medical revolution in which ailing organs and tissues might be repaired—not
Patents offer the economic guarantees scientists and companies need to develop new treatments, Oliver Bruestle told Deutsche Welle. He’s at the center of a German court battle surrounding embryonic stem cell research
Oliver Bruestle, director of the Institute of Reconstructive Neurobiology at the University of Bonn, is pushing for Germany to recognize the right to patent procedures conducted on embryonic stem cells, saying patents are the right way to ensure that scientists and companies profit from their work.
Greenpeace, however, is opposed to the patents. The organization filed suit against a patent granted to Bruestle in 1999, saying that the patenting